Circulation Research, Vol 63, 483-491, Copyright © 1988 by American Heart Association

ARTICLES

C5a decreases regional coronary blood flow and myocardial function in pigs: implications for a granulocyte mechanism

SE Martin, DE Chenoweth, RL Engler, DM Roth and JC Longhurst
Department of Medicine, University of California, San Diego, La Jolla.

Granulocytes cause some of the pathophysiological effects associated with the capillary no-reflow phenomenon during ischemia and in ischemia- reperfusion injury. However, no study has examined the consequences of in vivo granulocyte activation during normal perfusion pressures. In this study, we examined the effects of intracoronary administration of the complement component C5a, which is known to be a potent granulocyte activating factor. Nine open-chest, anesthetized pigs were instrumented to monitor regional coronary blood flow and segment shortening, left ventricular dP/dt, heart rate, and pulmonary artery and aortic blood pressures and to sample arterial and regional coronary venous blood for oxygen content and complete blood counts. Intracoronary infusion of human or porcine C5a in doses ranging from 10 to 500 ng produced a significant reduction in regional coronary blood flow and myocardial function. Although perfusion pressure and heart rate remained constant, venous oxygen content fell, indicating an imbalance between myocardial oxygen supply and demand. In addition, the arteriovenous difference of white blood cells was increased significantly after anaphylatoxin infusion, indicating intravascular trapping in the myocardium. Granulocytes accounted entirely for the differences in leukocyte counts because no significant changes in platelet, lymphocyte, or hematocrit levels were observed. Injection of vehicle alone did not alter any of the monitored variables.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				J. Szebeni, L. Baranyi, S. Savay, M. Bodo, J. Milosevits, C. R. Alving, and R. Bunger Complement activation-related cardiac anaphylaxis in pigs: role of C5a anaphylatoxin and adenosine in liposome-induced abnormalities in ECG and heart function Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1050 - H1058. [Abstract] [Full Text] [PDF]

				S. Y. Yuan, M. H. Wu, E. E. Ustinova, M. Guo, J. H. Tinsley, P. de Lanerolle, and W. Xu Myosin Light Chain Phosphorylation in Neutrophil-Stimulated Coronary Microvascular Leakage Circ. Res., June 14, 2002; 90(11): 1214 - 1221. [Abstract] [Full Text] [PDF]

				M. Tofukuji, G. L. Stahl, C. Metais, M. Tomita, A. Agah, C. Bianchi, M. P. Fink, and F. W. Sellke Mesenteric dysfunction after cardiopulmonary bypass: role of complement C5a Ann. Thorac. Surg., March 1, 2000; 69(3): 799 - 807. [Abstract] [Full Text] [PDF]

				C. Caliezi, W. A. Wuillemin, S. Zeerleder, M. Redondo, B. Eisele, and C. E. Hack C1-Esterase Inhibitor: An Anti-Inflammatory Agent and Its Potential Use in the Treatment of Diseases Other Than Hereditary Angioedema Pharmacol. Rev., March 1, 2000; 52(1): 91 - 112. [Abstract] [Full Text] [PDF]

				V. Stangl, O. Rodiger, T. M. Frank, M. Bohm, K. Stangl, G. Baumann, and S. B. Felix Influence of polymorphonuclear leukocytes and plasma on coronary vasomotion after ischemia Ann. Thorac. Surg., August 1, 1999; 68(2): 442 - 446. [Abstract] [Full Text] [PDF]

				J. Szebeni, J. L. Fontana, N. M. Wassef, P. D. Mongan, D. S. Morse, D. E. Dobbins, G. L. Stahl, R. Bunger, and C. R. Alving Hemodynamic Changes Induced by Liposomes and Liposome-Encapsulated Hemoglobin in Pigs : A Model for Pseudoallergic Cardiopulmonary Reactions to Liposomes: Role of Complement and Inhibition by Soluble CR1 and Anti-C5a Antibody Circulation, May 4, 1999; 99(17): 2302 - 2309. [Abstract] [Full Text] [PDF]

				P. Bugajski, R. Kalawski, I. Zurawska, M. Bartkowiak, H. Wysocki, R. Olszewski, and T. Siminiak Endothelin-1 is involved in plasma mediated stimulation of neutrophil adherence during coronary artery bypass grafting Eur. J. Cardiothorac. Surg., April 1, 1999; 15(4): 408 - 412. [Abstract] [Full Text] [PDF]

				M. Tofukuji, C. Metais, C. D. Collard, D. S. Morse, G. L. Stahl, D. P. Nelson, J. Li, M. Simons, and F. W. Sellke Effect of sialyl Lewisx oligosaccharide on myocardial and cerebral injury in the pig Ann. Thorac. Surg., January 1, 1999; 67(1): 112 - 119. [Abstract] [Full Text] [PDF]

				M. Tofukuji, G. L. Stahl, A. Agah, C. Metais, M. Simons, and F. W. Sellke ANTI-C5A MONOCLONAL ANTIBODY REDUCES CARDIOPULMONARY BYPASS AND CARDIOPLEGIA-INDUCED CORONARY ENDOTHELIAL DYSFUNCTION J. Thorac. Cardiovasc. Surg., December 1, 1998; 116(6): 1060 - 1069. [Abstract] [Full Text] [PDF]

				C. M. Goddard, B. Y. Poon, M. E. Klut, B. R. Wiggs, S. F. vanEeden, J. C. Hogg, and K. R. Walley Leukocyte activation does not mediate myocardial leukocyte retention during endotoxemia in rabbits Am J Physiol Heart Circ Physiol, November 1, 1998; 275(5): H1548 - H1557. [Abstract] [Full Text] [PDF]

				Q. Huang, M. Wu, C. Meininger, K. Kelly, and Y. Yuan Neutrophil-dependent augmentation of PAF-induced vasoconstriction and albumin flux in coronary arterioles Am J Physiol Heart Circ Physiol, October 1, 1998; 275(4): H1138 - H1147. [Abstract] [Full Text] [PDF]

				H. Weisman, T Bartow, M. Leppo, H. Marsh Jr, G. Carson, M. Concino, M. Boyle, K. Roux, M. Weisfeldt, and D. Fearon Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis Science, July 13, 1990; 249(4965): 146 - 151. [Abstract] [PDF]